IBDEI0ZC ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,17231,1,5,0)
 ;;=5^FAMILY HX-ALLERGIC DIS
 ;;^UTILITY(U,$J,358.3,17231,2)
 ;;=^295326
 ;;^UTILITY(U,$J,358.3,17232,0)
 ;;=V19.7^^88^1054^5
 ;;^UTILITY(U,$J,358.3,17232,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17232,1,4,0)
 ;;=4^V19.7
 ;;^UTILITY(U,$J,358.3,17232,1,5,0)
 ;;=5^FAMILY HX-CONSANGUINITY
 ;;^UTILITY(U,$J,358.3,17232,2)
 ;;=^44746
 ;;^UTILITY(U,$J,358.3,17233,0)
 ;;=V19.8^^88^1054^4
 ;;^UTILITY(U,$J,358.3,17233,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17233,1,4,0)
 ;;=4^V19.8
 ;;^UTILITY(U,$J,358.3,17233,1,5,0)
 ;;=5^FAMILY HX-CONDITION NEC
 ;;^UTILITY(U,$J,358.3,17233,2)
 ;;=^295327
 ;;^UTILITY(U,$J,358.3,17234,0)
 ;;=V40.0^^88^1055^4
 ;;^UTILITY(U,$J,358.3,17234,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17234,1,4,0)
 ;;=4^V40.0
 ;;^UTILITY(U,$J,358.3,17234,1,5,0)
 ;;=5^PROBLEMS WITH LEARNING
 ;;^UTILITY(U,$J,358.3,17234,2)
 ;;=^295424
 ;;^UTILITY(U,$J,358.3,17235,0)
 ;;=V40.1^^88^1055^3
 ;;^UTILITY(U,$J,358.3,17235,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17235,1,4,0)
 ;;=4^V40.1
 ;;^UTILITY(U,$J,358.3,17235,1,5,0)
 ;;=5^PROB WITH COMMUNICATION
 ;;^UTILITY(U,$J,358.3,17235,2)
 ;;=^295425
 ;;^UTILITY(U,$J,358.3,17236,0)
 ;;=V40.2^^88^1055^1
 ;;^UTILITY(U,$J,358.3,17236,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17236,1,4,0)
 ;;=4^V40.2
 ;;^UTILITY(U,$J,358.3,17236,1,5,0)
 ;;=5^MENTAL PROBLEMS NEC
 ;;^UTILITY(U,$J,358.3,17236,2)
 ;;=^295426
 ;;^UTILITY(U,$J,358.3,17237,0)
 ;;=V40.31^^88^1055^5
 ;;^UTILITY(U,$J,358.3,17237,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17237,1,4,0)
 ;;=4^V40.31
 ;;^UTILITY(U,$J,358.3,17237,1,5,0)
 ;;=5^WANDERING-DIS ELSEWHERE
 ;;^UTILITY(U,$J,358.3,17237,2)
 ;;=^340621
 ;;^UTILITY(U,$J,358.3,17238,0)
 ;;=V40.39^^88^1055^2
 ;;^UTILITY(U,$J,358.3,17238,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17238,1,4,0)
 ;;=4^V40.39
 ;;^UTILITY(U,$J,358.3,17238,1,5,0)
 ;;=5^OTH SPC BEHAVIOR PROBLEM
 ;;^UTILITY(U,$J,358.3,17238,2)
 ;;=^340622
 ;;^UTILITY(U,$J,358.3,17239,0)
 ;;=V42.0^^88^1056^15
 ;;^UTILITY(U,$J,358.3,17239,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17239,1,4,0)
 ;;=4^V42.0
 ;;^UTILITY(U,$J,358.3,17239,1,5,0)
 ;;=5^KIDNEY TRANSPLANT STATUS
 ;;^UTILITY(U,$J,358.3,17239,2)
 ;;=^121356
 ;;^UTILITY(U,$J,358.3,17240,0)
 ;;=V42.1^^88^1056^11
 ;;^UTILITY(U,$J,358.3,17240,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17240,1,4,0)
 ;;=4^V42.1
 ;;^UTILITY(U,$J,358.3,17240,1,5,0)
 ;;=5^HEART TRANSPLANT STATUS
 ;;^UTILITY(U,$J,358.3,17240,2)
 ;;=^54832
 ;;^UTILITY(U,$J,358.3,17241,0)
 ;;=V42.2^^88^1056^13
 ;;^UTILITY(U,$J,358.3,17241,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17241,1,4,0)
 ;;=4^V42.2
 ;;^UTILITY(U,$J,358.3,17241,1,5,0)
 ;;=5^HEART VALVE TRANSPLANT
 ;;^UTILITY(U,$J,358.3,17241,2)
 ;;=^295437
 ;;^UTILITY(U,$J,358.3,17242,0)
 ;;=V42.3^^88^1056^30
 ;;^UTILITY(U,$J,358.3,17242,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17242,1,4,0)
 ;;=4^V42.3
 ;;^UTILITY(U,$J,358.3,17242,1,5,0)
 ;;=5^SKIN TRANSPLANT STATUS
 ;;^UTILITY(U,$J,358.3,17242,2)
 ;;=^111158
 ;;^UTILITY(U,$J,358.3,17243,0)
 ;;=V42.4^^88^1056^5
 ;;^UTILITY(U,$J,358.3,17243,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17243,1,4,0)
 ;;=4^V42.4
 ;;^UTILITY(U,$J,358.3,17243,1,5,0)
 ;;=5^BONE TRANSPLANT STATUS
 ;;^UTILITY(U,$J,358.3,17243,2)
 ;;=^16243
 ;;^UTILITY(U,$J,358.3,17244,0)
 ;;=V42.5^^88^1056^7
 ;;^UTILITY(U,$J,358.3,17244,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17244,1,4,0)
 ;;=4^V42.5
 ;;^UTILITY(U,$J,358.3,17244,1,5,0)
 ;;=5^CORNEA TRANSPLANT STATUS
 ;;^UTILITY(U,$J,358.3,17244,2)
 ;;=^174117
 ;;^UTILITY(U,$J,358.3,17245,0)
 ;;=V42.6^^88^1056^21
 ;;
 ;;$END ROU IBDEI0ZC
